Anti-tumor necrosis factor-alpha monoclonalantibody. Effective in rheumathoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, ankylosing spondylitis.

HUNTERASE® is indicated for the long-term treatment of patients with Hunter syndrome (mucopolysaccharidosis type II, MPS II)